Continuous glucose monitor for diabetes on peritoneal dialysis
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether continuous glucose monitors (CGMs) work accurately in people doing peritoneal dialysis with icodextrin solution. It may help you manage your diabetes better by showing your glucose levels in real time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes for at least 3 months.
- You are 18 to 75 years old.
- You have been on peritoneal dialysis for at least 2 months.
- You are using or plan to use icodextrin PD solution within 3 months.
- No peritonitis in the last month and no plan to switch to hemodialysis or get a transplant soon.
- You are willing to avoid swimming during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a continuous glucose monitor (a small sensor that checks blood sugar levels throughout the day) can help improve diabetes control in people who are on peritoneal dialysis (a type of kidney dialysis done at home). It aims to see if this technology leads to better health outcomes.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
This study looks at whether using a continuous glucose monitor (a small sensor that checks blood sugar levels around the clock) can help people who were just diagnosed with type 2 diabetes manage their blood sugar better. If you join, you would wear the sensor for a while and get regular feedback, which might help you learn how food and habits affect your sugar levels.
This study tests whether using a small sensor (continuous glucose monitor) to check your blood sugar while you're in the hospital can improve diabetes management. You'll wear the sensor for a few days and may not need as many finger-prick tests.
Hear when a new Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.